baber/WOPTO huggingface dataset:
Patent AU-1225795-A (AU)
Title: Combinations of an organic nitrate and a salicylate
Inventor: BYRNE WILLIAM
IPC: A61K9/20
Filed: 1995-02-14
Abstract: A pharmaceutical composition comprises a single dose capsule for oral administration containing an organic nitrate, preferably isosorbide 5-mononitrate and acetylsalicylic acid. A coating on one or both of the organic nitrate or acetylsalicylic acid provides a barrier between them. Portion of the organic nitrate in the capsule is in a form for immediate release and portion is in a form for slow release.   <IMAGE>   <IMAGE>
Patent AU-1238300-A (AU)
Title: Multiple display system
Inventor: HAUGHEY CHARLES S
IPC: G09F11/02
Filed: 1999-10-26
Abstract: An apparatus for controlling a drive mechanism of a panel display system includes a rotary member attached to a drive assembly, the rotary member having indicators located at known intervals that are detected to ensure that the drive assembly starts and stops at precise locations. In a preferred embodiment, the control system is applied to a panel display system that displays different scenes using an array of elongated three-sided display elements. The preferred control system includes an aluminum disk that is attached to rotate in connection with rotation of the drive assembly.
Patent AU-1378395-A (AU)
Title: Metal chelators
Inventor: POLLAK ALFRED
IPC: A61K51/08
Filed: 1994-12-22
Abstract: Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy.
Patent AU-1450797-A (AU)
Title: Electrode for printer
Inventor: NEWCOMBE GUY CHARLES FERNLEY
IPC: B41J2/06
Filed: 1997-01-22
Abstract: An ejection apparatus for ejecting material from a liquid has an ejection cell (2) for containing the liquid in use. The cell (2) has a protrusion (3) disposed so as to be contacted by liquid in the cell on more than one side and defining a predetermined location for a meniscus of the liquid at an opening in the cell. An ejection electrode (6) is disposed in the cell at a position inwardly of the cell with respect to the predetermined location of the meniscus.
Patent AU-1456000-A (AU)
Title: Knuckle drive link conveyor belt systems
Inventor: BOGLE DAVID W
IPC: B65G17/06
Filed: 1999-10-28
Abstract: This invention provides integrated knuckle drive link conveyor belt systems with improved long wear-high load bearing link coupling joints of a universal joint nature for permitting the belts to travel on straight or curvaceous paths which also feature expedited insertion of spindle rods extending through the knuckles, diverse sprocket drive capabilities and replaceable load conveying platform accessories of the plug-in or snap-in variety. A cylindrical knuckle, when the loaded belt is under tension, has a substantially semi-cylindrical high wear contact surface that handles heavy peak loads. That knuckle is installed expeditiously at a joint between end-to-end connected links constituting a special interfitted jig comprising a seat in the nose end of a link resting the knuckle in a registered operational position to receive the connecting spindle rod through trailing edge bifurcated arms of a leading modular link without a concurrent manual orientation of the knuckle. Diverse sprocket drive structure permits the belt to be driven from beneath or on either lateral side. The knuckle and surrounding seat provides three dimensional moving tolerances to provide the universal joint type operation at each link joint. Other features include side rollers to reduce friction on inner curve radii, and hold down flanges that keep the belt from fluttering off a base support surface. The rugged molded resulting plastic links are long wearing and resist catastrophic failure. The versatility and ruggedness of the system is significantly enhanced by the removable platform structure for heavy industrial use.
Patent AU-1502901-A (AU)
Title: Device for connection and mechanism for manoeuvring a closure or solar protection installation comprising such device
Inventor: CATTANEO RINO
IPC: E06B9/17
Filed: 2001-01-17
Abstract: A connector for securing a side support for a roller shaft to a slideway for guiding closure selectively wound about the roller shaft wherein the connector includes a tab having a lower portion engaging the slideway and an upper portion engageable with the side support for the roller shaft. The connector further includes an elastic lock member insertable within an opening in the tab for securing the tab to the side support for the closure member by way of at least two resilient hooks associated with the elastic lock member which are engageable with the tab and the side support for the roller shaft.
Patent AU-1711495-A (AU)
Title: Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
Inventor: PERRON HERVE
IPC: C12N5/08
Filed: 1995-02-06
Abstract: Composition comprising two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of said virus, and a second agent, or a variant of said second agent, these two pathogenic and/or infective agents originating from the same viral strain chosen from the strains designated, respectively, POL-2 deposited with the ECACC on Jul. 22 1992 under Accession Number V92072202 and MS7PG deposited with the ECACC on Jan. 8 1993 under Accession Number V93010816, and from their variant strains.
Patent AU-1814101-A (AU)
Title: In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete ATP binding domain and is CD4+ cell-independent
Inventor: HUANG QIAN
IPC: A61K47/48
Filed: 2000-12-01
Abstract: The present invention relates to a method of inducing a CD8+ CTL response to a molecule in an individual deficient in CD4+ T cells comprising administering to the individual art hsp or a portion of an ATP binding domain of an hsp joined to the molecule. In one embodiment, the present invention relates to a method of treating HIV in an individual deficient in CD4+ T cells comprising administering to the individual an hsp or a portion of an ATP binding domain of an hsp joined to the molecule. Also encompassed by the present invention is a method of inducing a CD4+ independent CTL response in an individual comprising administering to the individual a portion of an ATP binding domain of an hsp joined to the molecule. The present invention also relates to a method of inducing a CD8+ CTL response in an individual comprising administering to the individual a portion of an ATP binding domain of an hsp joined to the molecule. In addition, the present invention relates to a composition characterized by a portion of an ATP biding domain of an hsp joined to a molecule.
Patent AU-1856188-A (AU)
Title: Process for drying textiles in a non-uniform fashion and resulting textile products
Inventor: RICCI FRANCESCO
IPC: D06L4/23
Filed: 1988-06-30
Abstract: A textile dyed in a non-uniform fashion characterized in that it has irregular, random, maculated patterns on its surface which vary in shape, size, intensity of colour shading and/or colour, and which are distributed in a non-uniform fashion over the surface of the textile, whereas other areas are undyed or have a light colour.
Patent AU-2177601-A (AU)
Title: Novel il-8 receptor antagonists
Inventor: PAQUET JEAN-LUC
IPC: A61K31/405
Filed: 2000-11-24
Abstract: The present invention relates to novel compounds which inhibit the action of CXC chemokines, such as IL-8, Gro, NAP-2, ENA-78 etc., on their receptors, to the process for their preparation and to their use for obtaining drugs.According to the invention, said compounds are novel indole derivatives selected from the group consisting of:i) the products of the formula in which:X is a double bond -C=C- or a sulfur atom;R1 is a halogen, a nitro group, a trifluoromethyl group or a C1-C3 alkyl group;R2, R3 and R4 are each independently a hydrogen atom, a halogen, a C1-C3 alkyl group, a nitro group, a trifluoromethyl group or a cyano group, or R2 and R3 form a fused aromatic ring together with the aromatic ring to which they are attached; andn is equal to 2 or 3; andii) esters of the compounds of formula I and addition salts of said compounds with a mineral or organic base.
Patent AU-2353101-A (AU)
Title: Ostomy bag with coupling
Inventor: HESSEL LASSE L
IPC: A61F5/448
Filed: 2001-01-05
Abstract: An ostomy bag with a wall of a flexible material and a first coupling member for detachably coupling the ostomy bag with an implant, for example an implant surrounding the stoma, with the first coupling member being and designed with a circumferential groove. The first coupling member is a spring ring composed of a spring wire having end parts extending a distance past each other. Along the opening of the ostomy bag, an edge reinforcement is made by joining of at least a part of the spring ring and an area of the wall of the ostomy bag, and on each end part of the spring wire is a handle for opening the spring ring on overcoming the spring power in the spring ring so that the edge reinforcement can pass over the circumferential groove of the implant at mounting and decoupling of the ostomy bag.
Patent AU-2365884-A (AU)
Title: Liquid sample handling system
Inventor: SALOMAA KARI
IPC: G01N1/28
Filed: 1984-01-20
Abstract: An automatic liquid transfer system includes a horizontally translatable table and a vertically translatable set of pipettes. The table accommodates a titer tray having a multiplicity of receptacles to be filled, or holding liquid samples to be diluted, and a rack housing plural rows of disposable tips. During each cycle in a serial dilution process, a fresh set of tips are picked up by the pipettes and used to transfer liquid in a sterile manner from a sample or diluent source to a row of wells in the titer tray, or from one row to a succeeding row of wells where it is mixed with diluent. Thereafter, the tips are discharged back into the rack to maintain sterile conditions during the process. A sensor is provided on the machine to detect whether all of the tips in each set are disengaged and another set successfully picked up.
Patent AU-2441488-A (AU)
Title: Driving apparatus
IPC: G09G3/36
Filed: 1988-10-26
Abstract: A driving apparatus comprises a driving unit and a drive voltage generating unit. The driving unit includes a scanning electrode driver and a data electrode driver for driving an electrode matrix formed of scanning electrodes and data electrodes. The drive voltage generating unit includes a first means for generating a fixed voltage, a second means for generating a source voltage for providing drive voltages for driving the electrode matrix, and a third means for generating a first voltage equal to a subtraction of the fixed voltage from the source voltage and a second voltage equal to a subtraction of the source voltage from the fixed voltage. The first and second voltages are preferably controlled so as to vary depending on an external temperature.
Patent AU-2581599-A (AU)
Title: Use of heregulin as an epithelial cell growth factor
Inventor: SLIWKOWSKI MARK
IPC: A61P11/00
Filed: 1999-02-03
Abstract: Ligands which bind to the HER2, HER3, and/or HER4 receptors are useful as normal epithelial cell growth factors.
Patent AU-2617300-A (AU)
Title: Techniques for permitting access across a context barrier on a small footprint device using an entry point object
Inventor: SUSSER JOSHUA
IPC: G06F9/46
Filed: 2000-01-20
Abstract: A small footprint device can securely run multiple programs from unrelated vendors by the inclusion of a context barrier isolating the execution of the programs. The context barrier performs security checks to see that principal and object are within the same namespace or memory space and to see that a requested action is appropriate for an object to be operated upon. Each program or set of programs runs in a separate context. Access from one program to another program across the context barrier can be achieved under controlled circumstances by using an entry point object. The entry point object can either perform accesses across the context barrier on behalf of a requesting program or can pass the request to the program to be accessed and switch contexts to the program to be accessed.
Patent AU-2668295-A (AU)
Title: Process for measuring the depth of a microstructure
Inventor: WILD HEINRICH
IPC: G01B11/22
Filed: 1995-06-10
Abstract: The proposal is for a process for measuring the depth of a microstructure on the transfer of the structure by means of a stamping process into a deformable layer, in which there is a geometrically simple reference grid structure in the microstructure to be transferred. This reference grid structure causes an interference of a measuring light beam. The colour distribution thus produced provides a measure of the structure depth obtained.
Patent AU-2679997-A (AU)
Title: Pyrazinone thrombin inhibitors
Inventor: SANDERSON PHILIP E
IPC: C07D405/14
Filed: 1997-04-18
Abstract: Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having structure (a), for example (b).
Patent AU-2698197-A (AU)
Title: Interaction of cyclin d1 and estrogen receptor and its use in assays
Inventor: BERNARDS RENE
IPC: G01N33/574
Filed: 1997-04-16
Abstract: PCT No. PCT/EP97/01888 Sec. 371 Date Apr. 6, 1999 Sec. 102(e) Date Apr. 6, 1999 PCT Filed Apr. 16, 1997 PCT Pub. No. WO97/40378 PCT Pub. Date Oct. 30, 1997The present invention relates to the finding that cyclin D1 interacts with estrogen receptor to provide activation of estrogen responsive genes. The present invention provides in vitro and in vivo assays to measure the interaction. The in vivo assays may be conducted in cells which grow in response to estrogen, particularly breast tumour cells.
Patent AU-2819692-A (AU)
Title: Process for manufacturing a composite product by moulding
IPC: B29C48/285
Filed: 1992-11-06
Abstract: Prod. comprises a thermoplastic organic material; e.g. polypropylene, polyamide or polyester; with fibre reinforcement eg. glass fibre; mineral and organic additives is made by moulding extrusion or injection from material supplied from an extruder where at least part of the organic material is fed in the form of strands or continuous filaments. The organic material and reinforcing fibres may be fed at the same or via two different feed entries, also the input may be a continuous filament which itself is a composite of reinforcement and organic material.
Patent AU-2869697-A (AU)
Title: Camera pedestal
Inventor: CHAPMAN LEONARD T
IPC: B62D7/04
Filed: 1997-07-16
Abstract: A camera dolly or pedestal (27) reduces unwanted sudden camera movement when the dolly wheels (104) roll over a bump or crack on the floor. The dolly wheels (104) have a rocker suspension (30) which can be used with a bogey wheel system (80) which offsets the dual wheel sets (104a, 104b) of the dolly (28). The dolly chassis may be advantageously split into two sections (202, 204) journalled together to achieve the benefit of both 3 point and 4 point suspensions. A column drive to achieve the benefit of both 3 point and 4 point suspensions. A column drive system (310) has a hydraulic actuator (306) to remotely raise the column assembly (300), and to lock the column assembly (300) into any selected position. <IMAGE>
Patent AU-2917202-A (AU)
Title: Canine support diet
Inventor: FREEMAN LISA M
IPC: A23L33/15
Filed: 2002-03-27
Abstract: The present invention provides a foodstuff comprising taurine, vitamin C, vitamin E and one or more polyunsaturated fatty acids, its use in the control of cardiovascular disorders, and its use in a method for controlling cardiovascular disorders.
Patent AU-2973800-A (AU)
Title: Dna vaccines against hantavirus infections
Inventor: SCHMALJOHN CONNIE S
IPC: A61P31/14
Filed: 2000-01-27
Abstract: Seoul virus (SEOV) is one of four known hantaviruses causing hemorrhagic fever with renal syndrome (HFRS). Candidate naked DNA vaccines for HFRS were constructed by subcloning cDNA representing the medium (M) (encoding the G1 and G2 glycoproteins) or small (S) (encoding the nucleocapsid protein) genome segment of SEOV into the DNA expression vector pWRG7077. We vaccinated BALB/c mice with three doses of the M or S DNA vaccine at 4-week intervals by either gene gun inoculation of the epidermis, or needle inoculation into the gastrocnemius muscle. Both routes of vaccination resulted in antibody responses as measured by ELISA; however, gene gun inoculation elicited a higher frequency of seroconversion, and higher levels of antibodies in individual mice. We vaccinated Syrian hamsters with the M or S construct using the gene gun and found hantavirus-specific antibodies in 5/5 and 4/5 hamsters, respectively. Animals vaccinated with the M construct developed a neutralizing antibody response which was greatly enhanced in the presence of guinea pig complement. Immunized hamsters were challenged with SEOV and, after 28 days, were monitored for evidence of infection. Hamsters vaccinated with M were protected from infection, but hamsters vaccinated with S were not protected.
Patent AU-3108993-A (AU)
Title: Improved apparatus and method for reliably detecting a depolarization activation wave of the heart and atrial defibrillator utilizing same
Inventor: ADAMS JOHN M
IPC: A61N1/39
Filed: 1993-01-07
Abstract: An atrial defibrillator (30) reliably detects a depolarization activation wave of the heart and delivers cardioverting electrical energy to the atria of the heart in synchronism with a detected depolarization activation wave. The atrial defibrillator includes a first sensor (53,52) for producing a first electrical output having a duration substantially equal to the duration of the depolarization activation wave sensed between a first pair of spaced apart locations (38a,40a) of the heart. The atrial defibrillator further includes a second sensor for producing a second electrical output having a duration substantially equal to the duration of the depolarization activation wave sensed between a second pair of spaced apart locations of the heart. The spacing between the second pair of locations is greater than the spacing between the first pair of locations. A microprocessor (60) is responsive to the first and second electrical outputs for providing an indication signal indicating the occurrence of the depolarization activation wave when the second electrical output is longer in duration than the first electrical output. A pulse generator (66) coupled to the microprocessor applies electrical cardioverting energy to the atria of the heart in response to the indication signal. <IMAGE>
Patent AU-3126889-A (AU)
Title: Thickened pourable aqueous cleaner
Inventor: CHOY CLEMENT K
IPC: C11D3/395
Filed: 1989-03-13
Abstract: This invention provides a thickened aqueous hard surface cleaner composition comprising colloidal alumina as the thickener in an aqueous cleaner which comprises a surfactant, electrolyte/buffer, soap and organic solvent system. These cleaner composition systems, which are the fluent, all-purpose type of cleaners, have surprising properties when thickened with the colloidal alumina. Such cleaners when thickened with colloidal alumina have a smoothly flowable or plastic consistency, and in their most preferred form, are pourable at room temperature, which consistency is not thixotropic in nature.
Patent AU-3238500-A (AU)
Title: Hydrogenated block copolymers
Inventor: BATES FRANK S
IPC: C08F297/04
Filed: 2000-02-23
Abstract: The present invention is a hydrogenated pentablock copolymer prepared by hydrogenating a pentablock copolymer produced from a vinyl aromatic monomer and a conjugated diene monomer, having the structure ABABA, wherein each vinyl aromatic polymer block (A) is hydrogenated to greater than 90 percent and each conjugated diene polymer block (B) is hydrogenated to greater than 95 percent.
Patent AU-3238893-A (AU)
Title: Improved electrochemiluminescent label for DNA probe assays
Inventor: GUDIBANDE SATYANARAYANA R
IPC: C12Q1/68
Filed: 1992-12-07
Abstract: This invention relates to a new electrochemiluminescent (ECL) label for oligonucleotides using phosphoramidite chemistry.
Patent AU-3569497-A (AU)
Title: Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1
Inventor: LOPEZ-BERESTEIN GABRIEL
IPC: A61P35/02
Filed: 1997-07-08
Abstract: The present invention provides novel compositions and methods for use in the treatment of cancer, specifically, in the treatment chronic myelogenous leukemia (CML). The compositions contain antisense oligonucleotides that hybridize to Grb2 and Crk1 nucleic acids, the gene products of which are known to interact with the tumorigenic protein bcr-abl. Used alone, in conjunction with each other, and even in conjunction with antisense oligonucleotides directed to bcr-abl nucleic acids, these compositions inhibit the proliferation of CML cancer cells.
Patent AU-3632493-A (AU)
Title: Itraconazole and saperconazole stereoisomers
Inventor: HEERES JAN
IPC: C07D521/00
Filed: 1993-03-10
Abstract: Anti-infective compositions for the treatment of a human in need of therapy for a systemic or topical fungal infection which comprise a pharmaceutically acceptable carrier and a therapeutically effective amount of (2R,4S) itraconazole or a pharmaceutically acceptable salt thereof, substantially free of its (2S,4R) stereoisomer.
Patent AU-3652993-A (AU)
Title: New use of omega-3-fatty acids
Inventor: EGBERG NILS
IPC: A61K36/55
Filed: 1993-02-23
Abstract: PCT No. PCT/SE93/00146 Sec. 371 Date Oct. 21, 1994 Sec. 102(e) Date Oct. 21, 1994 PCT Filed Feb. 23, 1993 PCT Pub. No. WO93/16691 PCT Pub. Date Sep. 2, 1993The present invention relates to omega-3-fatty acid containing preparations for the treatment of Disseminated Intravascular Coagulation (DIC) and symptoms related to DIC, as well as such preparations for reducing a pathological increase in pulmonary artery pressure (PAP). The preparations may be in the form of emulsions, or aerosols for inhalation, of an oil or phospholipids or other derivatives or salts of omega-3-fatty acids of marine and/or vegetable origin with a significant content of omega-3-fatty acids. The preparations may also be in tablet or capsule form for oral use.
Patent AU-3741801-A (AU)
Title: Substituted beta-carbolines with ikb-kinase inhibiting activity
Inventor: RITZELER OLAF
IPC: A61P17/02
Filed: 2001-02-28
Abstract: The subject matter of the present invention is directed to novel substituted beta-carbolines, and specifically compounds of the formula I, which are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of IkappaB kinase is involved.
Patent AU-3810100-A (AU)
Title: Stable pharmaceutical application form for paroxetin anhydrate
Inventor: FISCHER GERHARD
IPC: A61K47/44
Filed: 2000-03-10
Abstract: Medicaments in the form of soft gelatin capsules contain paroxetin anhydrate or pharmaceutically acceptable salts thereof together with lipophilic carriers, namely silicone oils.
Patent AU-3950999-A (AU)
Title: Method for improving appearance in composite color-plus-clear coatings, and compositions for use therein
Inventor: HARMON HERBERT
IPC: C08G18/62
Filed: 1999-04-30
Abstract: The invention provides composite color-plus-clear coatings having improved appearance, especially with respect to wrinkling, and to methods and compositions for providing such coatings. The method of the invention utilizes a second coating composition comprising (A) a film forming component comprising (a) a first component comprising a compound having appended thereto at least one carbamate or urea functional group, or a group convertible to a carbamate or urea group, and (b) a second component comprising a compound reactive with said carbamate or urea groups on component (a), (B) a cyclic anhydride, and (C) a catalyst.